#Toronto #Australia #Clario #Xtalks #Digital Endpoints

Exploring Digital Endpoints: Transforming Early and Mid-Phase Development

In the rapidly evolving landscape of clinical trials, ensuring robust methodologies for validating and selecting digital endpoints is essential. This upcoming free webinar, hosted by Xtalks, will provide valuable insights for professionals engaged in early and mid-phase studies, shedding light on how to enhance your research outcomes.

Understanding Digital Endpoints

Digital endpoints are becoming increasingly popular in clinical trials, especially in early development phases. They encompass a variety of metrics obtained through digital technologies, such as electronic Clinical Outcome Assessments (eCOA), imaging, and patient-reported outcomes. These endpoints help in generating reliable data and can be crucial when making pivotal development decisions.

The webinar will cover the following key areas:

• - Scientific Rigor: Learn what makes an endpoint scientifically robust and suitable for early-phase development.
• - Operational Considerations: Understand the requirements to ensure the successful implementation of digital endpoints, including site readiness, training, data quality, and managing complexities across various Clinical Research Organizations (CROs).
• - Feasibility Assessment: Delve into how early-phase studies can refine endpoints, ensuring they are not only scientifically valid but also practical and scalable.

Key Speakers

The session will feature a panel of experts, including:

• - Todd Rudo, MD: Chief Medical Officer at Clario, who will act as the moderator for the discussion.
• - Tina Soulis: Founder and Director of Alithia Life Sciences, bringing invaluable insights from Australia's early-phase clinical trial ecosystem.
• - Kelly Dumais, PhD: Senior Director at Clario, focusing on eCOA Science and Consulting, who will discuss insights into designing digital endpoints.
• - Anu Bansal, MD: Vice President of Medical Imaging, Oncology at Clario, who will address the role of medical imaging in early oncology trials.

Strategic Importance of Early Digital Strategies

The exploration of Australia’s clinical trial infrastructure will serve as a practical example during the webinar. Early digital strategies can provide a scalable foundation for later-phase success, aligning global operations with local capabilities. By implementing digital endpoints effectively in early and mid-phase development, organizations can enhance evidence generation and boost regulatory confidence.

Register Now

Don’t miss out on this opportunity to enhance your understanding of digital endpoints that are essential in clinical trials. Join us live on March 10, 2026, at 11 AM AEDT / March 9, 2026, at 8 PM EST. You can register here to secure your spot and gain insights that could transform your operational processes.

About Xtalks

Xtalks is committed to empowering professionals in pharma, biotech, medtech, and healthcare with reliable knowledge and collaborative insights. Each year, Xtalks hosts numerous webinars and articles designed to keep the life science community informed of industry developments.

Stay up-to-date with the latest in drug development practices by being part of this insightful event. Join Xtalks for a comprehensive look at how digital endpoint strategies can reshape the clinical research landscape for the better.